Theodore Daniel Zucconi insider trades: Galectin Therapeutics (GALT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Theodore reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 16, 2018 | GALT | ↓ Sell | 4,000 | $3.58 | $14K | Direct | Apr 18, 2018 (2d) |
| May 23, 2017 | GALT | ↑ Buy | 1,000 | $2.27 | $2K | Direct | May 24, 2017 (1d) |
| Sep 19, 2008 | PRW | ↑ Buy | 2,000 | $0.23 | $451 | Direct | Sep 23, 2008 (4d) |
| Sep 18, 2008 | PRW | ↑ Buy | 9,000 | $0.22 | $2K | Direct | Sep 22, 2008 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GALT insiders
Open-market trades in the last 12 months
About Theodore Daniel Zucconi's insider trades
Theodore Daniel Zucconi is a director at Galectin Therapeutics (GALT). Since Sep 18, 2008, Theodore has reported 3 open-market purchases worth $5K and 1 sale worth $14K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (8 filings), option exercises (2 filings), other transactions (1 filing), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GALT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.